BCL2 and hepatocellular carcinoma: Recent data demonstrated that CAFs released soluble CXCL12 into the HCC microenvironment and activated CXCL12/CXCR4/PI3K/AKT signaling of neighboring HCC cells, which subsequently alleviated apoptosis by elevating the BCL-2/BAX ratio.